BeautyHealth (NASDAQ:SKIN) Beats Q4 Sales Targets, Stock Jumps 19.6%
Skincare company BeautyHealth (NASDAQ:SKIN) reported results ahead of analysts' expectations in Q4 FY2023, with revenue down 1.4% year on year to $96.8 million. On the other hand, next quarter's revenue guidance of $80 million was less impressive, coming in 6.4% below analysts' estimates. It made a GAAP loss of $0.07 per share, down from its loss of $0.02 per share in the same quarter last year.